BioAffinity Technologies announces pricing of $3.25M offering

WallachBeth Capital announced that bioAffinity Technologies (BIAF) priced a best efforts offering of securities for aggregate gross proceeds to the company of $3.25M, before deducting agent fees and other estimated expenses payable by the company. The offering consists of 10.16M shares of common stock together with warrants to initially purchase up to 15.23M shares of common stock. The combined public offering price for each share of common stock and accompanying warrant is 32c. The closing of the offering is expected to occur on or about May 7, subject to the satisfaction of customary closing conditions. WallachBeth Capital is acting as sole placement agent for the offering.